Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,158.03. The company's market cap stands at 1.09T, with a P/E ratio of 42.09 and a dividend yield of 0.55%.
During the trading session on 2026-07-23, Eli Lilly(LLY) shares reached a daily high of $1,159.00 and a low of $1,156.77. At a current price of $1,158.03, the stock is +0.1% higher than the low and still -0.1% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 6.06K, versus its average volume of 2.32M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
LLY News
Eli Lilly (LLY) on Thursday announced plans to seek FDA approval for its next-gen weight-loss therapy, retatrutide, early next year after the triple hormone rec...
...
Eli Lilly (LLY) announced topline results from TRIUMPH-2 and TRIUMPH-3, two Phase 3 trials evaluating retatrutide, an investigational, first-in-class GIP, GLP-1...
Analyst ratings
81%
of 31 ratingsMore LLY News
Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide. Scott Olson / Getty Images Eli Lilly LLY -1.05 %decrease; d...
Eli Lilly on Thursday said it will file for approval of its next-generation obesity drug in the first quarter of 2027, as the treatment succeeds in two more lat...
Eli Lilly launched its FDA approved Alzheimer's drug Kisunla, adding a new treatment option to its neuroscience portfolio. The company is preparing prominent p...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...
Top Stock Picks for Week of July 20, 2026 A Vital Supplier of AI Infrastructure and a Renewable Energy Company with a Significant EPS Increase Projected Descrip...
Stocks To Watch: 14 Names Test And Tease New Buy Zones 7/08/2026 A barrage of stocks to watch like Eli Lilly and Deere, show promise, alongside reminders to ke...
Key Points Novo Nordisk has sued rival GLP-1 drugmaker Eli Lilly in federal court, alleging misleading advertising. Novo alleges that Lilly's ads compare a lo...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.